Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.
Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM, Dingemans AC, Fournier B, Hurkmans C, Lecouvet FE, Meattini I, Méndez Romero A, Ricardi U, Russell NS, Schanne DH, Scorsetti M, Tombal B, Verellen D, Verfaillie C, Ost P. Guckenberger M, et al. Among authors: meattini i. Lancet Oncol. 2020 Jan;21(1):e18-e28. doi: 10.1016/S1470-2045(19)30718-1. Lancet Oncol. 2020. PMID: 31908301 Review.
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society.
Pegurri L, Buglione M, Girelli G, Guarnieri A, Meattini I, Ricardi U, Mangoni M, Gabriele P, Bellavita R, Krengli M, Bonetta A, Cagna E, Bunkheila F, Borghesi S, Signor M, Di Marco A, Bertoni F, Stefanacci M, Gatta R, De Bari B, Magrini SM. Pegurri L, et al. Among authors: meattini i. Tumori. 2014 Jan-Feb;100(1):31-7. doi: 10.1700/1430.15812. Tumori. 2014. PMID: 24675488
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study).
Meattini I, Pasinetti N, Meduri B, De Rose F, De Santis MC, Franco P, Lancellotta V, Rossi F, Saieva C, Desideri I, Delli Paoli C, D'Angelo E, Triggiani L, Bastiani P, Alongi F, Lozza L, Aristei C, Ricardi U, Scorsetti M, Livi L; Clinical Oncology Breast Cancer Group (COBCG) Investigators. Meattini I, et al. Radiother Oncol. 2019 Feb;131:208-214. doi: 10.1016/j.radonc.2018.07.015. Epub 2018 Jul 31. Radiother Oncol. 2019. PMID: 30075864 Free article.
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy.
Arcangeli S, Jereczek-Fossa BA, Alongi F, Aristei C, Becherini C, Belgioia L, Buglione M, Caravatta L, D'Angelillo RM, Filippi AR, Fiore M, Genovesi D, Greco C, Livi L, Magrini SM, Marvaso G, Mazzola R, Meattini I, Merlotti A, Palumbo I, Pergolizzi S, Ramella S, Ricardi U, Russi E, Trovò M, Sindoni A, Valentini V, Corvò R. Arcangeli S, et al. Among authors: meattini i. Crit Rev Oncol Hematol. 2019 Feb;134:87-103. doi: 10.1016/j.critrevonc.2018.11.005. Epub 2018 Dec 1. Crit Rev Oncol Hematol. 2019. PMID: 30658886 Review.
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity.
Arcangeli S, Jereczek-Fossa BA, Alongi F, Aristei C, Becherini C, Belgioia L, Buglione M, Caravatta L, D'Angelillo RM, Filippi AR, Fiore M, Genovesi D, Greco C, Livi L, Magrini SM, Marvaso G, Mazzola R, Meattini I, Merlotti A, Palumbo I, Pergolizzi S, Ramella S, Ricardi U, Russi E, Trovò M, Sindoni A, Valentini V, Corvò R. Arcangeli S, et al. Among authors: meattini i. Crit Rev Oncol Hematol. 2019 Feb;134:104-119. doi: 10.1016/j.critrevonc.2018.11.006. Epub 2018 Nov 30. Crit Rev Oncol Hematol. 2019. PMID: 30658887 Review.
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Jereczek-Fossa BA, Pepa M, Marvaso G, Bruni A, Buglione di Monale E Bastia M, Catalano G, Filippi AR, Franco P, Gambacorta MA, Genovesi D, Iatì G, Magli A, Marafioti L, Meattini I, Merlotti A, Mignogna M, Musio D, Pacelli R, Pergolizzi S, Tombolini V, Trovò M, Ricardi U, Magrini SM, Corvò R, Donato V; AIRO (Italian Association of Radiotherapy and Clinical Oncology). Jereczek-Fossa BA, et al. Among authors: meattini i. Radiother Oncol. 2020 Aug;149:89-93. doi: 10.1016/j.radonc.2020.04.061. Epub 2020 May 12. Radiother Oncol. 2020. PMID: 32413527 Free PMC article.
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 - EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures.
Meattini I, Poortmans PMP, Marrazzo L, Desideri I, Brain E, Hamaker M, Lambertini M, Miccinesi G, Russell N, Saieva C, Strnad V, Visani L, Kaidar-Person O, Livi L. Meattini I, et al. J Geriatr Oncol. 2021 Mar;12(2):182-189. doi: 10.1016/j.jgo.2020.07.013. Epub 2020 Jul 29. J Geriatr Oncol. 2021. PMID: 32739355 Clinical Trial.
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2.
Jereczek-Fossa BA, Pepa M, Zaffaroni M, Marvaso G, Bruni A, Buglione di Monale E Bastia M, Catalano G, Filippi AR, Franco P, Gambacorta MA, Genovesi D, Iatì G, Magli A, Marafioti L, Meattini I, Merlotti A, Mignogna M, Musio D, Pacelli R, Pergolizzi S, Tombolini V, Trovo M, Leonardi MC, Ricardi U, Magrini SM, Corvò R, Donato V; on the behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology). Jereczek-Fossa BA, et al. Among authors: meattini i. Radiother Oncol. 2021 Feb;155:120-122. doi: 10.1016/j.radonc.2020.09.049. Epub 2020 Oct 14. Radiother Oncol. 2021. PMID: 33065185 Free PMC article. No abstract available.
271 results